Sort
82,697 grants matching “vaccine development”
The mucosal immune system: effects of aging and chronic antigenic stimulation
$1,008,586Rita Brickman Effros · University Of California Los Angeles · R01 · FY2011 · AG
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,008,580Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Preclinical Evaluation of Novel Ad/MVA and Ad/Protein HIV-1 Vaccines
$1,008,188Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2013 · AI
Epidemiology, transmission and immunology of COVID-19 in nursing home residents
$1,008,129David H Canaday · Case Western Reserve University · R01 · FY2020 · AI
DCP - Biopharmaceutical Development Program (BDP) Support
$1,008,067Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2021 · CA
Experimental characterization of the dynamics of immune responses to influenza
$1,008,020Rafi Ahmed · Emory University · U19 · FY2015 · AI
SARS-CoV-2 Studies
$1,007,948Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
COBRE Phase III: Transitional Center for Research on Processes in Evolution
$1,007,868Larry J Forney · University Of Idaho · P30 · FY2015 · GM
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$1,007,817Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
PEDIATRIC AIDS CLINICAL TRIALS UNIT
$1,007,797New York University School Of Medicine · U01 · FY2000 · AI
CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
$1,007,764Myron S Cohen · Family Health International · UM1 · FY2023 · AI
Induction of protective t-cell responses to HIV-1
$1,007,730Andrew James McMichael · Duke University · UM1 · FY2016 · AI
MUCOSAL IMMUNITY AND INFECTION
$1,007,539Case Western Reserve University · P01 · FY2003 · AI
Tuberculosis Research Unit
$1,007,535W. Henry Henry Boom · Case Western Reserve University · N01 · FY2010 · AI
Newborn cohorts to discover and validate biomarkers of neonatal vaccine immunogenicity
$1,007,530Ofer Levy · Boston Children'S Hospital · U19 · FY2018 · AI
Scanning B. pseudomallei proteome for vaccine antigens
$1,007,395University Of California Irvine · U01 · FY2005 · AI
Autoimmunity: Mechanisms of Unresponsiveness
$1,007,289Charles Garrison Fathman · Stanford University · P01 · FY2006 · AI
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
$1,007,282Roy Curtiss · University Of Florida · R01 · FY2015 · AI
Novel Vaccine Technology for Chikungunya
$1,007,233Scott C Weaver · University Of Texas Med Br Galveston · R01 · FY2011 · AI
Laboratory Support
$1,007,157Wendy Stevens · Wits Health Consortium (Pty), Ltd · U19 · FY2009 · AI
Factors Contributing To Immune-Enhanced Disease In The Pathogenesis of RSV
$1,006,825Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Development of Inhaled CPZEN-45 For Tuberculosis Therapy
$1,006,759Anthony James Hickey · Research Triangle Institute · R01 · FY2019 · AI
VANDERBILT ADULT AIDS CLINICAL TRIALS UNIT
$1,006,278David W Haas · Vanderbilt University · U01 · FY2006 · AI
Operations Core
$1,006,216William Paul Duprex · University Of Pittsburgh At Pittsburgh · UC7 · FY2024 · AI
Non-invasive Optical Imaging of Select Agent Bacteria in Non-human Primates
$1,006,212Frederick D Quinn · University Of Georgia · U01 · FY2010 · AI